Tatva Chintan Pharma Chem Limited — Others, 24-07-2025: Change in Director(s)

Tatva Chintan Pharma Chem's Board has approved its financial results for the quarter ended June 30, 2025. The company reported a consolidated net profit of ₹6.65 Cr on a total income of ₹118.02 Cr. Standalone net profit stood at ₹5.13 Cr with a total income of ₹108.94 Cr. The Board also approved the re-appointment of its Managing Director and two Whole-time Directors for a one-year term, and three Independent Directors for a five-year term, all subject to shareholder approval. Additionally, the Chief Financial Officer, Mr. Ashok Bothra, has resigned, effective August 30, 2025. This impacts leadership and financial oversight.